Oesophageal cancer

Hong Yang(Sun Yat-sen University), Jianhua Fu(Sun Yat-sen University), Christopher L. Hallemeier(Mayo Clinic in Arizona), Feng Wang(Sun Yat-sen University)

The Lancet

November 1, 2024

10.1016/s0140-6736(24)02226-8

Cited by 265

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies

|Nature Reviews Clinical Oncology|2017|1.7k

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

|Annals of Surgery|2019|445

Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon

|Stroke|2006|337

External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline

|Practical Radiation Oncology|2021|261

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

|Nature Medicine|2024|162